Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo

被引:202
作者
Sundstedt, A
O'Neill, EJ
Nicolson, KS
Wraith, DC
机构
[1] Active Biotech Res, S-22007 Lund, Sweden
[2] Univ Bristol, Sch Med, Dept Pathol & Microbiol, Bristol, Avon, England
关键词
D O I
10.4049/jimmunol.170.3.1240
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory CD4(+) T cells were induced in the Tg4 TCR transgenic mouse specific for the N-terminal peptide (Acl-9) of myelin basic protein by intranasal administration of a high-affinity MHC-binding analog (Acl-9[4Y]). Peptide-induced tolerant cells (PItol) were anergic, failed to produce IL-2, but responded to Ag by secretion of IL-10. PItol cells were predominantly CD25(-) and CTLA-4(+) and their anergic state was reversed by addition of IL-2 in vitro. PItol cells suppressed the response of naive Tg4 cells both in vitro and in vivo. The in vitro suppression mediated by these cells was not reversed by cytokine neutralization and was cell-cell contact-dependent. However, suppression of proliferation and IL-2 production by PItol cells in vivo was abrogated by neutralization of IL-10. These results emphasize an important role for IL-10 in the function of peptide-induced regulatory T cells in vivo and highlight the caution required in extrapolating mechanisms of T regulatory cell function from in vitro studies.
引用
收藏
页码:1240 / 1248
页数:9
相关论文
共 65 条
[11]   ISOLATION OF MYELIN BASIC PROTEIN-REACTIVE T-CELL LINES FROM NORMAL HUMAN-BLOOD [J].
BURNS, J ;
ROSENZWEIG, A ;
ZWEIMAN, B ;
LISAK, RP .
CELLULAR IMMUNOLOGY, 1983, 81 (02) :435-440
[12]   Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23) [J].
Daniel, D ;
Wegmann, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :956-960
[13]   Endogenous interleukia-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis [J].
Deckert, M ;
Soltek, S ;
Geginat, G ;
Lütjen, S ;
Montesinos-Rongen, M ;
Hof, H ;
Schlüter, D .
INFECTION AND IMMUNITY, 2001, 69 (07) :4561-4571
[14]   Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells [J].
Dhodapkar, MV ;
Steinman, RM ;
Krasovsky, J ;
Munz, C ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :233-238
[15]   ICOS co-stimulatory receptor is essential for T-cell activation and function [J].
Dong, C ;
Juedes, AE ;
Temann, UA ;
Shresta, S ;
Allison, JP ;
Ruddle, NH ;
Flavell, RA .
NATURE, 2001, 409 (6816) :97-101
[16]   Oral tolerance: Mechanisms and therapeutic applications [J].
Faria, AMC ;
Weiner, HL .
ADVANCES IN IMMUNOLOGY, VOL 73, 1999, 73 :153-264
[17]  
Gazzinelli RT, 1996, J IMMUNOL, V157, P798
[18]   CTLA-4 regulates induction of anergy in vivo [J].
Greenwald, RJ ;
Boussiotis, VA ;
Lorsbach, RB ;
Abbas, AK ;
Sharpe, AH .
IMMUNITY, 2001, 14 (02) :145-155
[19]   A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis [J].
Groux, H ;
OGarra, A ;
Bigler, M ;
Rouleau, M ;
Antonenko, S ;
deVries, JE ;
Roncarolo, MG .
NATURE, 1997, 389 (6652) :737-742
[20]   IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common γ-chain of the IL-2 receptor [J].
Grundström, S ;
Dohlsten, M ;
Sundstedt, A .
JOURNAL OF IMMUNOLOGY, 2000, 164 (03) :1175-1184